Mersana to focus on advancing cancer treatment XMT-1356 Jan. 4, 2019 at 7:04 a.m. ETby Tomi Kilgore Mersana Therapeutics to discontinue development of cancer treatment XMT-1522 Jan. 4, 2019 at 7:04 a.m. ETby Tomi Kilgore CORRECTED: Salarius, Flex Pharma to merge to accelerate developmen...
61 8 9226 1356 Website www.polarx.com.au Earnings Revisions Sorry, this data cannot be displayed at the moment. Valuation Sorry, this data cannot be displayed at the moment. Growth Profitability Sorry, this data cannot be displayed at the moment. ...